Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–72. https://doi.org/10.1001/archopht.122.4.564.
Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013. Eye (Lond). 2016;30(4):602–7. https://doi.org/10.1038/eye.2015.288.
Article CAS PubMed Google Scholar
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.
Article CAS PubMed Google Scholar
Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008;145(2):239–48. https://doi.org/10.1016/j.ajo.2007.10.004.
Article CAS PubMed Google Scholar
Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology. 2011;118(5):831–9. https://doi.org/10.1016/j.ophtha.2010.09.004.
Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A, Tamura H, Ooto S, Tsujikawa A, Yoshimura N. Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study. Ophthalmology. 2015;122(11):2303–10. https://doi.org/10.1016/j.ophtha.2015.06.053.
Cho JH, Ryoo NK, Cho KH, Park SJ, Park KH, Woo SJ. Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2016;169:79–88. https://doi.org/10.1016/j.ajo.2016.06.014.
Jaffe GJ, Ying GS, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG. Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2019;126(2):252–60. https://doi.org/10.1016/j.ophtha.2018.08.035.
Kaiser PK, Wykoff CC, Singh RP, Khanani AM, Do DV, Patel H, Patel N. Retinal fluid and thickness as measures of disease activity in neovascular age-related macular degeneration. Retina. 2021;41(8):1579–86. https://doi.org/10.1097/iae.0000000000003194.
Article CAS PubMed PubMed Central Google Scholar
Simader C, Ritter M, Bolz M, Deák GG, Mayr-Sponer U, Golbaz I, Kundi M, Schmidt-Erfurth UM. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Ophthalmology. 2014;121(6):1237–45. https://doi.org/10.1016/j.ophtha.2013.12.029.
Burlina PM, Joshi N, Pekala M, Pacheco KD, Freund DE, Bressler NM. Automated grading of age-related macular degeneration from color fundus images using deep convolutional neural networks. JAMA Ophthalmol. 2017;135(11):1170–6. https://doi.org/10.1001/jamaophthalmol.2017.3782.
Article PubMed PubMed Central Google Scholar
Treder M, Lauermann JL, Eter N. Automated detection of exudative age-related macular degeneration in spectral domain optical coherence tomography using deep learning. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):259–65. https://doi.org/10.1007/s00417-017-3850-3.
Article CAS PubMed Google Scholar
Hwang DK, Hsu CC, Chang KJ, Chao D, Sun CH, Jheng YC, Yarmishyn AA, Wu JC, Tsai CY, Wang ML, et al. Artificial intelligence-based decision-making for age-related macular degeneration. Theranostics. 2019;9(1):232–45. https://doi.org/10.7150/thno.28447.
Article PubMed PubMed Central Google Scholar
Gutfleisch M, Ester O, Aydin S, Quassowski M, Spital G, Lommatzsch A, Rothaus K, Dubis AM, Pauleikhoff D. Clinically applicable deep learning-based decision aids for treatment of neovascular AMD. Graefes Arch Clin Exp Ophthalmol. 2022;260(7):2217–30. https://doi.org/10.1007/s00417-022-05565-1.
Article CAS PubMed Google Scholar
Bogunovic H, Waldstein SM, Schlegl T, Langs G, Sadeghipour A, Liu X, Gerendas BS, Osborne A, Schmidt-Erfurth U. Prediction of anti-VEGF treatment requirements in neovascular AMD using a machine learning approach. Invest Ophthalmol Vis Sci. 2017;58(7):3240–8. https://doi.org/10.1167/iovs.16-21053.
Article CAS PubMed Google Scholar
Gallardo M, Munk MR, Kurmann T, De Zanet S, Mosinska A, Karagoz IK, Zinkernagel MS, Wolf S, Sznitman R. Machine learning can predict anti-VEGF treatment demand in a treat-and-extend regimen for patients with neovascular AMD, DME, and RVO associated macular edema. Ophthalmol Retina. 2021;5(7):604–24. https://doi.org/10.1016/j.oret.2021.05.002.
Rohm M, Tresp V, Müller M, Kern C, Manakov I, Weiss M, Sim DA, Priglinger S, Keane PA, Kortuem K. Predicting visual acuity by using machine learning in patients treated for neovascular age-related macular degeneration. Ophthalmology. 2018;125(7):1028–36. https://doi.org/10.1016/j.ophtha.2017.12.034.
Fu DJ, Faes L, Wagner SK, Moraes G, Chopra R, Patel PJ, Balaskas K, Keenan TDL, Bachmann LM, Keane PA. Predicting incremental and future visual change in neovascular age-related macular degeneration using deep learning. Ophthalmol Retina. 2021;5(11):1074–84. https://doi.org/10.1016/j.oret.2021.01.009.
Abbas A, O’Byrne C, Fu DJ, Moraes G, Balaskas K, Struyven R, Beqiri S, Wagner SK, Korot E, Keane PA. Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2022;260(8):2461–73. https://doi.org/10.1007/s00417-021-05544-y.
Article PubMed PubMed Central Google Scholar
Refaeilzadeh P, Tang L, Liu H. Cross-validation. Encyclopedia Database Syst. 2009;5:532–8.
Melinščak M, Radmilović M, Vatavuk Z, Lončarić S. Annotated retinal optical coherence tomography images (AROI) database for joint retinal layer and fluid segmentation. Automatika. 2021;62(3–4):375–85.
Ronneberger O, Fischer P, Brox T. U-net: Convolutional networks for biomedical image segmentation. In: Navab N, Hornegger J, Wells W, Frangi A, editors. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. MICCAI 2015. Lecture Notes in Computer Science, vol 9351. Cham: Springer; 2015. https://doi.org/10.1007/978-3-319-24574-4_28.
Jadon S. A survey of loss functions for semantic segmentation. In: 2020 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB): 2020: IEEE; 2020. p. 1–7. https://arxiv.org/abs/2006.14822.
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. Proc IEEE Conf Comp Vis Pattern Recognit. 2016;2016:770–8.
Tercan H, Guajardo A, Heinisch J, Thiele T, Hopmann C, Meisen T. Transfer-learning: Bridging the gap between real and simulation data for machine learning in injection molding. Procedia Cirp. 2018;72:185–90.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–6. https://doi.org/10.1097/JTO.0b013e3181ec173d.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.
Article CAS PubMed Google Scholar
Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-cam: Visual explanations from deep networks via gradient-based localization. Proc IEEE Int Conf Comput Vis. 2017;2017:618–26.
Schmidt-Erfurth U, Waldstein SM, Klimscha S, Sadeghipour A, Hu X, Gerendas BS, Osborne A, Bogunovic H. Prediction of individual disease conversion in early AMD using artificial intelligence. Invest Ophthalmol Vis Sci. 2018;59(8):3199–208. https://doi.org/10.1167/iovs.18-24106.
Article CAS PubMed Google Scholar
Ajana S, Cougnard-Grégoire A, Colijn JM, Merle BMJ, Verzijden T, de Jong P, Hofman A, Vingerling JR, Hejblum BP, Korobelnik JF, et al. Predicting progression to advanced age-related macular degeneration from clinical, genetic, and lifestyle factors using machine learning. Ophthalmology. 2021;128(4):587–97. https://doi.org/10.1016/j.ophtha.2020.08.031.
Pfau M, Sahu S, Rupnow RA, Romond K, Millet D, Holz FG, Schmitz-Valckenberg S, Fleckenstein M, Lim JI, de Sisternes L, et al. Probabilistic forecasting of anti-VEGF treatment frequency in neovascular age-related macular degeneration. Transl Vis Sci Technol. 2021;10(7):30. https://doi.org/10.1167/tvst.10.7.30.
Article PubMed PubMed Central Google Scholar
Chandra RS, Ying GS. Evaluation of multiple machine learning models for predicting number of anti-VEGF injections in the Comparison of AMD Treatment Trials (CATT). Transl Vis Sci Technol. 2023;12(1):18. https://doi.org/10.1167/tvst.12.1.18.
Article PubMed PubMed Central Google Scholar
Romo-Bucheli D, Erfurth US, Bogunovic H. End-to-End Deep learning model for predicting treatment requirements in neovascular AMD from longitudinal retinal OCT imaging. IEEE J Biomed Health Inform. 2020;24(12):3456–65. https://doi.org/10.1109/jbhi.2020.3000136.
Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina. 2010;30(9):1333–49. https://doi.org/10.1097/IAE.0b013e3181e7976b.
Nagiel A, Sarraf D, Sadda SR, Spaide RF, Jung JJ, Bhavsar KV, Ameri H, Querques G, Freund KB. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina. 2015;35(4):638–47. https://doi.org/10.1097/iae.0000000000000488.
Comments (0)